Wall Street brokerages forecast that Israel Chemicals Ltd (NYSE:ICL) will report earnings of $0.09 per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Israel Chemicals’ earnings. Israel Chemicals posted earnings per share of $0.11 in the same quarter last year, which suggests a negative year-over-year growth rate of 18.2%. The company is expected to report its next quarterly earnings report on Wednesday, February 13th.
On average, analysts expect that Israel Chemicals will report full-year earnings of $0.37 per share for the current year. For the next year, analysts anticipate that the business will post earnings of $0.38 per share. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Israel Chemicals.
Israel Chemicals (NYSE:ICL) last announced its quarterly earnings data on Thursday, November 1st. The basic materials company reported $0.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.01. The company had revenue of $1.37 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Israel Chemicals had a net margin of 23.84% and a return on equity of 13.67%. The business’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.09 EPS.
Several brokerages have recently issued reports on ICL. Zacks Investment Research raised shares of Israel Chemicals from a “sell” rating to a “hold” rating in a research note on Tuesday, October 30th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $6.57 price objective on shares of Israel Chemicals in a research note on Sunday, October 21st. ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research note on Friday, August 24th. Finally, BMO Capital Markets reaffirmed a “hold” rating and issued a $5.25 price objective on shares of Israel Chemicals in a research note on Wednesday, September 19th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Israel Chemicals currently has a consensus rating of “Hold” and an average price target of $5.69.
Shares of ICL traded down $0.04 during mid-day trading on Friday, hitting $6.44. The company’s stock had a trading volume of 224,621 shares, compared to its average volume of 224,791. The stock has a market capitalization of $8.26 billion, a P/E ratio of 20.77, a P/E/G ratio of 1.88 and a beta of 1.07. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.34 and a quick ratio of 0.73. Israel Chemicals has a fifty-two week low of $3.85 and a fifty-two week high of $6.90.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Stockholders of record on Tuesday, December 4th will be given a $0.051 dividend. This is an increase from Israel Chemicals’s previous quarterly dividend of $0.04. This represents a $0.20 annualized dividend and a dividend yield of 3.17%. The ex-dividend date is Monday, December 3rd. Israel Chemicals’s dividend payout ratio (DPR) is 32.26%.
Institutional investors have recently added to or reduced their stakes in the company. Lourd Capital LLC purchased a new position in shares of Israel Chemicals in the third quarter worth approximately $167,000. AXA purchased a new position in shares of Israel Chemicals in the third quarter worth approximately $181,000. Janus Henderson Group PLC purchased a new position in shares of Israel Chemicals in the third quarter worth approximately $201,000. Eqis Capital Management Inc. purchased a new position in shares of Israel Chemicals in the second quarter worth approximately $245,000. Finally, BlackRock Inc. increased its position in shares of Israel Chemicals by 13.9% in the first quarter. BlackRock Inc. now owns 113,993 shares of the basic materials company’s stock worth $483,000 after acquiring an additional 13,942 shares in the last quarter. 8.10% of the stock is currently owned by institutional investors and hedge funds.
About Israel Chemicals
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Featured Story: Retained Earnings
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.